Ayşegül Öztürk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ayşegül Öztürk has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Arzuhan Çeti̇nDağ Çi̇lTaş
Sivas cumhuriyet üniversitesi, Sağlık Hizmetleri Meslek Yüksekokulu
3 shared publications - Ahmet Sevki Taskiran
Sivas Cumhuriyet University School of Medicine
2 shared publications - Sebahattin Karabulut
Sivas Cumhuriyet Üniversitesi
2 shared publications - Ahmet Kemal Filiz
Sivas Cumhuriyet Üniversitesi
1 shared publication Ahmet Şevki Taşkıran
Department of Physiology, Medicine Faculty, Sivas Cumhuriyet University, Sivas, Türkiye
1 shared publication- Ali Gungor
Laboratory Technician and Veterinary Health Program, Vocational School of Health Services, Osmaniye Korkut Ata University, Osmaniye 80000, Turkey
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by Hitit University in Hitit Medical Journal
- Vol. 8 (3) , 626-635
Single-Agent Effects of Pantoprazole and Omeprazole on the Viability of Doxorubicin-Adapted MCF-7 Breast Cancer Cells
Objective: Breast cancer remains a major cause of cancer-related mortality worldwide. Although doxorubicin (DOX) is widely used in breast cancer therapy, the emergence of resistance substantially reduces its clinical efficacy. Proton pump inhibitors (PPIs) may influence tumour biology by modulating the cellular microenvironment. This study aimed to evaluate the single-agent effects of pantoprazole and omeprazole on the viability of MCF-7 breast cancer cells adapted to increasing concentrations of doxorubicin.Materials and Methods: In this study, the human breast cancer cell line MCF-7 was utilized. Doxorubicin-adapted cells (MCF-7/DOX-A) were developed in vitro by exposing MCF-7 cells to gradually increasing concentrations of DOX. Following the adaptation protocol, the cells were used in subsequent experiments; a resistant phenotype was not independently verified. Pantoprazole and omeprazole were administered to the DOX-adapted MCF-7 cells at concentrations of 50, 25, 12.5, and 6.25 μM. Cell viability was evaluated using the XTT colorimetric assay, and the resulting data were subjected to statistical analysis. Statistical significance was defined as p0.05).Conclusion: Pantoprazole and omeprazole did not significantly alter the viability of MCF-7/DOX-A cells at the tested concentrations. These results do not exclude effects on other cellular outcomes.
- 14 October 2026
- Published by Hitit University in Hitit Medical Journal
- Vol. 8 (3) , 626-635
Open AccessSingle-Agent Effects of Pantoprazole and Omeprazole on the Viability of Doxorubicin-Adapted MCF-7 Breast Cancer Cells
Objective: Breast cancer remains a major cause of cancer-related mortality worldwide. Although doxorubicin (DOX) is widely used in breast cancer therapy, the emergence of resistance substantially reduces its clinical efficacy. Proton pump inhibitors (PPIs) may influence tumour biology by modulating the cellular microenvironment. This study aimed to evaluate the single-agent effects of pantoprazole and omeprazole on the viability of MCF-7 breast cancer cells adapted to increasing concentrations of doxorubicin.Materials and Methods: In this study, the human breast cancer cell line MCF-7 was utilized. Doxorubicin-adapted cells (MCF-7/DOX-A) were developed in vitro by exposing MCF-7 cells to gradually increasing concentrations of DOX. Following the adaptation protocol, the cells were used in subsequent experiments; a resistant phenotype was not independently verified. Pantoprazole and omeprazole were administered to the DOX-adapted MCF-7 cells at concentrations of 50, 25, 12.5, and 6.25 μM. Cell viability was evaluated using the XTT colorimetric assay, and the resulting data were subjected to statistical analysis. Statistical significance was defined as p0.05).Conclusion: Pantoprazole and omeprazole did not significantly alter the viability of MCF-7/DOX-A cells at the tested concentrations. These results do not exclude effects on other cellular outcomes.
- Open Access
- 27 September 2026
- Published by Kastamonu University in Kastamonu Medical Journal
- Vol. 6 (3) , 254-262
Galium aparine L. extract inhibits the proliferation of HT-29 cells and induces apoptosis
Aims: Galium Aparine L. (G. aparine) has been traditionally used as a medicinal herb for the treatment of cancer, fever, hypertension. This study aimed to evaluate the potential anticancer effects of G. aparine in HT-29 colon cancer cells and to investigate the molecular mechanisms that may be involved in these effects.Methods: The LC/Q-TOF/MS analysis was employed to conduct a qualitative phytochemical characterization of G. aparine. To evaluate the potential anticolorectal cancer effects of G. aparine, HT-29 cells were pretreated with G. aparine. Then, cell viability was examined by XTT assay, cell cycle distribution by flow cytometry and cell death by annexin V assay. In addition, the effect of G. aparine treatment on epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase- 1 (ERK-1), ERK-2, and apoptotic markers caspase-3 and Bcl-2-associated agonist of cell death (BAD) levels were investigated by ELISA method.Results: Following treatment with G. aparine, HT-29 cells exhibit increased apoptosis and cell cycle inhibition at the G0/G1 phase, as evidenced by the Annexin V binding assay (p<0.05). Moreever, G. aparine treatment significantly decreased EGFR and ERK-1 levels (p0.05). The apoptotic impact of G. aparine was additionally verified through ELISA assays evaluating the levels of BAD and caspase 3 (p<0.05).Conclusion: Taken together, the results demonstrate that G. aparine extract exerts significant anti-colorectal cancer effects by promoting apoptosis and inhibiting EGFR/ERK signaling.
- 27 September 2026
- Published by Kastamonu University in Kastamonu Medical Journal
- Vol. 6 (3) , 254-262
Open AccessGalium aparine L. extract inhibits the proliferation of HT-29 cells and induces apoptosis
Aims: Galium Aparine L. (G. aparine) has been traditionally used as a medicinal herb for the treatment of cancer, fever, hypertension. This study aimed to evaluate the potential anticancer effects of G. aparine in HT-29 colon cancer cells and to investigate the molecular mechanisms that may be involved in these effects.Methods: The LC/Q-TOF/MS analysis was employed to conduct a qualitative phytochemical characterization of G. aparine. To evaluate the potential anticolorectal cancer effects of G. aparine, HT-29 cells were pretreated with G. aparine. Then, cell viability was examined by XTT assay, cell cycle distribution by flow cytometry and cell death by annexin V assay. In addition, the effect of G. aparine treatment on epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase- 1 (ERK-1), ERK-2, and apoptotic markers caspase-3 and Bcl-2-associated agonist of cell death (BAD) levels were investigated by ELISA method.Results: Following treatment with G. aparine, HT-29 cells exhibit increased apoptosis and cell cycle inhibition at the G0/G1 phase, as evidenced by the Annexin V binding assay (p<0.05). Moreever, G. aparine treatment significantly decreased EGFR and ERK-1 levels (p0.05). The apoptotic impact of G. aparine was additionally verified through ELISA assays evaluating the levels of BAD and caspase 3 (p<0.05).Conclusion: Taken together, the results demonstrate that G. aparine extract exerts significant anti-colorectal cancer effects by promoting apoptosis and inhibiting EGFR/ERK signaling.
- Open Access
- 22 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4657
Apigenin as a Multitarget Anticancer Agent: Coordinated Inhibition of EGFR/MAPK and PI3K/Akt Signaling in Hematologic Malignancies
Hematologic malignancies are driven by dysregulated growth and survival signaling pathways that promote proliferation, treatment resistance, and disease progression. Naturally derived compounds targeting multiple oncogenic pathways with low toxicity have gained interest. Apigenin, a dietary flavonoid, shows anticancer activity in solid tumors, but its molecular effects in hematologic malignancies remain unclear. The antineoplastic effects of apigenin were evaluated in K562 (chronic myeloid leukemia) and DOHH2 (B-cell lymphoma) cell lines. Cell viability was assessed using the CCK-8 assay. L929 (mouse fibroblast) cells were included to evaluate selectivity. EGFR, MAPK, PI3K, NF-κB, caspase-3, and caspase-7 levels were measured by ELISA. Apoptosis and cell cycle distribution were analyzed by flow cytometry. Apigenin reduced cell viability in a dose-dependent manner, with IC50 values of 84.14 μM (K562) and 70.11 μM (DOHH2). It suppressed EGFR, MAPK, PI3K, and NF-κB signaling and increased the caspase-3 and caspase-7 levels (p < 0.001). Flow cytometry showed S-phase arrest and increased apoptosis. L929 cells showed limited reduction in viability at higher concentrations. Apigenin exerts antiproliferative and pro-apoptotic effects via inhibition of the EGFR/MAPK and PI3K/Akt pathways and activation of caspase-mediated apoptosis. Lower sensitivity in L929 cells suggests relative selectivity, supporting further in vivo and clinical studies.
- 22 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4657
Open AccessApigenin as a Multitarget Anticancer Agent: Coordinated Inhibition of EGFR/MAPK and PI3K/Akt Signaling in Hematologic Malignancies
Hematologic malignancies are driven by dysregulated growth and survival signaling pathways that promote proliferation, treatment resistance, and disease progression. Naturally derived compounds targeting multiple oncogenic pathways with low toxicity have gained interest. Apigenin, a dietary flavonoid, shows anticancer activity in solid tumors, but its molecular effects in hematologic malignancies remain unclear. The antineoplastic effects of apigenin were evaluated in K562 (chronic myeloid leukemia) and DOHH2 (B-cell lymphoma) cell lines. Cell viability was assessed using the CCK-8 assay. L929 (mouse fibroblast) cells were included to evaluate selectivity. EGFR, MAPK, PI3K, NF-κB, caspase-3, and caspase-7 levels were measured by ELISA. Apoptosis and cell cycle distribution were analyzed by flow cytometry. Apigenin reduced cell viability in a dose-dependent manner, with IC50 values of 84.14 μM (K562) and 70.11 μM (DOHH2). It suppressed EGFR, MAPK, PI3K, and NF-κB signaling and increased the caspase-3 and caspase-7 levels (p < 0.001). Flow cytometry showed S-phase arrest and increased apoptosis. L929 cells showed limited reduction in viability at higher concentrations. Apigenin exerts antiproliferative and pro-apoptotic effects via inhibition of the EGFR/MAPK and PI3K/Akt pathways and activation of caspase-mediated apoptosis. Lower sensitivity in L929 cells suggests relative selectivity, supporting further in vivo and clinical studies.
- Open Access
- 29 April 2026
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
- Vol. 10 (1) , 98-107
Anticancer and Antimicrobial Properties of Passiflora Incarnata
Purpose: Passiflora incarnata is a notable medicinal plant recognized for its therapeutic properties, largely attributed to its flavonoid and phenolic content. This study aimed to investigate the cytotoxic, oxidative stress-inducing, apoptotic, and antimicrobial effects of P. incarnata.Materials and Methods: Cytotoxicity was assessed using the XTT assay in SNU-1 gastric cancer cells, determining the IC₅₀ value as 88.95 μg/mL. Oxidative stress markers were evaluated via Total Antioxidant Capacity (TAC) and Total Oxidative Status (TOS) kits. Apoptotic activity was analyzed using BAD and Caspase-3 ELISA kits. Antimicrobial effects were tested against six microorganisms—three Gram-negative bacteria (Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, and Pseudomonas aeruginosa ATCC 278538539), two Gram-positive bacteria (Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212), and one yeast (Candida albicans ATCC 10231)—via the agar disk diffusion method. Statistical significance was defined as p
- 29 April 2026
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
- Vol. 10 (1) , 98-107
Open AccessAnticancer and Antimicrobial Properties of Passiflora Incarnata
Purpose: Passiflora incarnata is a notable medicinal plant recognized for its therapeutic properties, largely attributed to its flavonoid and phenolic content. This study aimed to investigate the cytotoxic, oxidative stress-inducing, apoptotic, and antimicrobial effects of P. incarnata.Materials and Methods: Cytotoxicity was assessed using the XTT assay in SNU-1 gastric cancer cells, determining the IC₅₀ value as 88.95 μg/mL. Oxidative stress markers were evaluated via Total Antioxidant Capacity (TAC) and Total Oxidative Status (TOS) kits. Apoptotic activity was analyzed using BAD and Caspase-3 ELISA kits. Antimicrobial effects were tested against six microorganisms—three Gram-negative bacteria (Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, and Pseudomonas aeruginosa ATCC 278538539), two Gram-positive bacteria (Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212), and one yeast (Candida albicans ATCC 10231)—via the agar disk diffusion method. Statistical significance was defined as p
- 30 March 2026
- Published by Bingol Universitesi in Türk Doğa ve Fen Dergisi
- Vol. 15 (1) , 43-49
The Effect of Pantoprazole, a Proton Pump Inhibitor, on Wound Healing in L929 Fibroblast Cells
Aim: This study aimed to investigate the potential effects of pantoprazole on wound healing using the L929 fibroblast cell line. Specifically, its impact on cell viability, oxidative stress markers, and the in vitro wound healing process was evaluated.Material and Method: L929 fibroblast cells were treated with pantoprazole at concentrations between 2.5 and 40 μM for 24 hours to assess cell viability. To evaluate oxidative balance, 2.5 μM pantoprazole was applied, and total antioxidant status (TAS) and total oxidant status (TOS) were measured. For wound healing analysis, a scratch assay was performed by creating a standardized wound area (0.9 × 1.8 mm), and cell migration toward the wound was evaluated at 24-, 36-, and 48-hours post-treatment.Results: Pantoprazole showed a concentration-dependent cytotoxic effect at doses between 5 and 40 μM (p < 0.05 to p < 0.001), while 2.5 μM significantly enhanced cell viability (p < 0.01). TAS levels were significantly increased (p < 0.05), with no significant change in TOS (p > 0.05). Wound closure was significantly improved at 48 hours in the pantoprazole-treated group (p < 0.05), though earlier time points showed no statistical difference.Conclusion: At low concentrations, pantoprazole enhances fibroblast viability, boosts antioxidant status, and accelerates wound healing, indicating potential therapeutic utility in tissue repair and oxidative stress modulation.
- 30 March 2026
- Published by Bingol Universitesi in Türk Doğa ve Fen Dergisi
- Vol. 15 (1) , 43-49
The Effect of Pantoprazole, a Proton Pump Inhibitor, on Wound Healing in L929 Fibroblast Cells
Aim: This study aimed to investigate the potential effects of pantoprazole on wound healing using the L929 fibroblast cell line. Specifically, its impact on cell viability, oxidative stress markers, and the in vitro wound healing process was evaluated.Material and Method: L929 fibroblast cells were treated with pantoprazole at concentrations between 2.5 and 40 μM for 24 hours to assess cell viability. To evaluate oxidative balance, 2.5 μM pantoprazole was applied, and total antioxidant status (TAS) and total oxidant status (TOS) were measured. For wound healing analysis, a scratch assay was performed by creating a standardized wound area (0.9 × 1.8 mm), and cell migration toward the wound was evaluated at 24-, 36-, and 48-hours post-treatment.Results: Pantoprazole showed a concentration-dependent cytotoxic effect at doses between 5 and 40 μM (p < 0.05 to p < 0.001), while 2.5 μM significantly enhanced cell viability (p < 0.01). TAS levels were significantly increased (p < 0.05), with no significant change in TOS (p > 0.05). Wound closure was significantly improved at 48 hours in the pantoprazole-treated group (p < 0.05), though earlier time points showed no statistical difference.Conclusion: At low concentrations, pantoprazole enhances fibroblast viability, boosts antioxidant status, and accelerates wound healing, indicating potential therapeutic utility in tissue repair and oxidative stress modulation.
- Open Access
- 18 August 2025
- Published by SDU Journal of Health Sciences in Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 16 (2) , 212-219
Pregabalinin Glutamat Eksitotoksisitesine Karşı Nöroprotektif Etkinliğinde Oksidatif ve Nitrozatif Yolların Rolü
Amaç: Bu çalışma pregabalinin nitrik oksit ve oksidatif stres yolakları üzerinden glutamat ile indüklenen sitotoksisite üzerindeki nöroprotektif etkisini araştırmak için tasarlandı. Gereç ve Yöntem: Deneyde C6 glioma hücre hattı kullanılmıştır. Pregabalinin glutamatın neden olduğu sitotoksisiteden sonra glial hücre ölümü üzerindeki etkisini değerlendirmek için dört grup oluşturuldu. Kontrol grubu herhangi bir işlem görmedi. Glutamat grubundaki hücreler 24 saat 10 mM glutamat ile muamele edildi. Pregabalin grubundaki hücreler, 24 saat boyunca çeşitli konsantrasyonlarda (3,75; 7,5; 15; 30 ve 60µM) pregabalin ile muamele edildi. Pregabalin+glutamat grubundaki hücreler, 1 saat boyunca çeşitli konsantrasyonlarda (3,75; 7,5; 15; 30 ve 60µM) pregabalin ile ön işleme tabi tutuldu ve ardından 24 saat boyunca 10mM glutamata maruz bırakıldı. Hücre canlılığı, XTT tahlili ile değerlendirildi. Hücrelerdeki toplam antioksidan ve oksidan seviyesi (TAS-TOS), indüklenebilir nitrik oksit (iNOS), nitrik oksit (NO) ve nöronal nitrik oksit (nNOS) seviyeleri ticari kitlerle ölçüldü. Bulgular: 30 ve 60 µM konsantrasyondaki pregabalin, glutamatın neden olduğu sitotoksisiteden sonra C6 hücrelerinde hücre canlılığını önemli ölçüde arttırdı (p
- 18 August 2025
- Published by SDU Journal of Health Sciences in Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 16 (2) , 212-219
Open AccessPregabalinin Glutamat Eksitotoksisitesine Karşı Nöroprotektif Etkinliğinde Oksidatif ve Nitrozatif Yolların Rolü
Amaç: Bu çalışma pregabalinin nitrik oksit ve oksidatif stres yolakları üzerinden glutamat ile indüklenen sitotoksisite üzerindeki nöroprotektif etkisini araştırmak için tasarlandı. Gereç ve Yöntem: Deneyde C6 glioma hücre hattı kullanılmıştır. Pregabalinin glutamatın neden olduğu sitotoksisiteden sonra glial hücre ölümü üzerindeki etkisini değerlendirmek için dört grup oluşturuldu. Kontrol grubu herhangi bir işlem görmedi. Glutamat grubundaki hücreler 24 saat 10 mM glutamat ile muamele edildi. Pregabalin grubundaki hücreler, 24 saat boyunca çeşitli konsantrasyonlarda (3,75; 7,5; 15; 30 ve 60µM) pregabalin ile muamele edildi. Pregabalin+glutamat grubundaki hücreler, 1 saat boyunca çeşitli konsantrasyonlarda (3,75; 7,5; 15; 30 ve 60µM) pregabalin ile ön işleme tabi tutuldu ve ardından 24 saat boyunca 10mM glutamata maruz bırakıldı. Hücre canlılığı, XTT tahlili ile değerlendirildi. Hücrelerdeki toplam antioksidan ve oksidan seviyesi (TAS-TOS), indüklenebilir nitrik oksit (iNOS), nitrik oksit (NO) ve nöronal nitrik oksit (nNOS) seviyeleri ticari kitlerle ölçüldü. Bulgular: 30 ve 60 µM konsantrasyondaki pregabalin, glutamatın neden olduğu sitotoksisiteden sonra C6 hücrelerinde hücre canlılığını önemli ölçüde arttırdı (p
- Open Access
- 30 June 2025
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 46 (2) , 268-273
The Effect of NKCC1 Inhibitor Azosemide on Emotional Behaviors and Hippocampal GABA Levels in a Rat Model of Post-traumatic Stress Disorder
Post-traumatic stress disorder (PTSD) is an anxiety disorder that can occur immediately or years after exposure to a traumatic event. Despite extensive research, the etiology of PTSD is largely unknown, but it is thought that impaired GABAergic transmission may play a role in the disease process. Using a single prolonged stress (SPS) procedure, we aimed to determine the effect of azosemide, a sodium-potassium-chloride cotransporter (NKCC1) inhibitor, on anxiety and memory-related behaviors and hippocampal GABA level in rats. Behavioral tests were performed by open field test and passive avoidance test, while hippocampal GABA levels were determined by ELISA. We found that azosemide treatment partially improved emotional behavior and significantly improved memory performance in rats with PTSD, without affecting the decline in hippocampal GABA levels induced by a SPS exposure. These findings suggest that azosemide may offer partial therapeutic benefits for symptoms of PTSD, particularly cognitive deficits. However, they underscore the necessity for multimodal approaches to address the various neurobiological underpinnings of the disorder.
- 30 June 2025
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 46 (2) , 268-273
Open AccessThe Effect of NKCC1 Inhibitor Azosemide on Emotional Behaviors and Hippocampal GABA Levels in a Rat Model of Post-traumatic Stress Disorder
Post-traumatic stress disorder (PTSD) is an anxiety disorder that can occur immediately or years after exposure to a traumatic event. Despite extensive research, the etiology of PTSD is largely unknown, but it is thought that impaired GABAergic transmission may play a role in the disease process. Using a single prolonged stress (SPS) procedure, we aimed to determine the effect of azosemide, a sodium-potassium-chloride cotransporter (NKCC1) inhibitor, on anxiety and memory-related behaviors and hippocampal GABA level in rats. Behavioral tests were performed by open field test and passive avoidance test, while hippocampal GABA levels were determined by ELISA. We found that azosemide treatment partially improved emotional behavior and significantly improved memory performance in rats with PTSD, without affecting the decline in hippocampal GABA levels induced by a SPS exposure. These findings suggest that azosemide may offer partial therapeutic benefits for symptoms of PTSD, particularly cognitive deficits. However, they underscore the necessity for multimodal approaches to address the various neurobiological underpinnings of the disorder.
- 30 June 2025
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 46 (2) , 304-309
Comparative Analysis of Sciatic Nerve Ligation and Oxaliplatin-Induced Neuropathic Pain Models: Thermal Nociception and Inflammatory Mechanisms
Neuropathic pain, resulting from damage or dysfunction of the nervous system, presents significant clinical challenges due to its chronic nature and resistance to treatment. This study compared the thermal nociception and inflammatory mechanisms of two neuropathic pain models: Sciatic nerve ligation (SNL) and oxaliplatin-induced peripheral neuropathy. Male Wistar Albino rats were randomly assigned to control, SNL, and oxaliplatin-induced neuropathy. The SNL model was established through partial sciatic nerve ligation, while oxaliplatin (4 mg/kg) was administered intraperitoneally twice weekly for four weeks. Thermal nociception was evaluated using tail-flick and hot-plate tests, and inflammatory markers (TNF-α and IL-1β) were measured in dorsal root ganglia(DRG) tissue and serum using ELISA. Thermal analgesia tests revealed that neuropathic pain symptoms appeared from the second week in the oxaliplatin group and from the fourth week in both models (p
- 30 June 2025
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 46 (2) , 304-309
Comparative Analysis of Sciatic Nerve Ligation and Oxaliplatin-Induced Neuropathic Pain Models: Thermal Nociception and Inflammatory Mechanisms
Neuropathic pain, resulting from damage or dysfunction of the nervous system, presents significant clinical challenges due to its chronic nature and resistance to treatment. This study compared the thermal nociception and inflammatory mechanisms of two neuropathic pain models: Sciatic nerve ligation (SNL) and oxaliplatin-induced peripheral neuropathy. Male Wistar Albino rats were randomly assigned to control, SNL, and oxaliplatin-induced neuropathy. The SNL model was established through partial sciatic nerve ligation, while oxaliplatin (4 mg/kg) was administered intraperitoneally twice weekly for four weeks. Thermal nociception was evaluated using tail-flick and hot-plate tests, and inflammatory markers (TNF-α and IL-1β) were measured in dorsal root ganglia(DRG) tissue and serum using ELISA. Thermal analgesia tests revealed that neuropathic pain symptoms appeared from the second week in the oxaliplatin group and from the fourth week in both models (p
- Open Access
- 30 May 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (7) , 1-9
Investigating the antiproliferative mechanisms of NaHS, a hydrogen sulfide donor, in the SH-SY5Y cell line
Neuroblastoma, a childhood cancer, arises from neural crest cells within the sympathetic nervous system. This study investigated the anticancer effects of the exogenous hydrogen sulfide (H₂S) donor, sodium hydrogen sulfide (NaHS), on neuroblastoma cells, elucidating how it inhibits cell proliferation. The study was conducted using the SH-SY5Y cell line. The cells were exposed to various concentrations of NaHS (32, 16, 8, 4, and 2 mM) for 24 h. Cell viability was assessed using the XTT assay. ELISA was used to measure levels of the growth signal factors HER-2, EGFR, mTOR, ERK-1, and ERK-2, as well as the apoptosis marker caspase-3. In addition, apoptosis was evaluated using the Muse Annexin V & Dead Cell Assay Kit. NaHS significantly reduced cell proliferation, as demonstrated by the XTT assay (p < 0.001). NaHS treatment also decreased levels of HER-2, EGFR, ERK-1, and ERK-2 (p < 0.05 to p < 0.01), while mTOR levels remained unchanged (p > 0.05) and caspase-3 levels increased (p < 0.001). Flow cytometry confirmed that NaHS treatment significantly increased the proportion of apoptotic cells (p < 0.001). The antiproliferative effect of NaHS against neuroblastoma appears to be mediated through the suppression of certain growth signal factors and the induction of apoptosis. These findings suggest that exogenous hydrogen sulfide donors hold promise as a potential therapeutic strategy for neuroblastoma.
- 30 May 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (7) , 1-9
Open AccessInvestigating the antiproliferative mechanisms of NaHS, a hydrogen sulfide donor, in the SH-SY5Y cell line
Neuroblastoma, a childhood cancer, arises from neural crest cells within the sympathetic nervous system. This study investigated the anticancer effects of the exogenous hydrogen sulfide (H₂S) donor, sodium hydrogen sulfide (NaHS), on neuroblastoma cells, elucidating how it inhibits cell proliferation. The study was conducted using the SH-SY5Y cell line. The cells were exposed to various concentrations of NaHS (32, 16, 8, 4, and 2 mM) for 24 h. Cell viability was assessed using the XTT assay. ELISA was used to measure levels of the growth signal factors HER-2, EGFR, mTOR, ERK-1, and ERK-2, as well as the apoptosis marker caspase-3. In addition, apoptosis was evaluated using the Muse Annexin V & Dead Cell Assay Kit. NaHS significantly reduced cell proliferation, as demonstrated by the XTT assay (p < 0.001). NaHS treatment also decreased levels of HER-2, EGFR, ERK-1, and ERK-2 (p < 0.05 to p < 0.01), while mTOR levels remained unchanged (p > 0.05) and caspase-3 levels increased (p < 0.001). Flow cytometry confirmed that NaHS treatment significantly increased the proportion of apoptotic cells (p < 0.001). The antiproliferative effect of NaHS against neuroblastoma appears to be mediated through the suppression of certain growth signal factors and the induction of apoptosis. These findings suggest that exogenous hydrogen sulfide donors hold promise as a potential therapeutic strategy for neuroblastoma.
- Open Access
- 1 April 2025
- Published by Bor Dergisi in Journal of Boron
- Vol. 10 (1) , 1-9
The role of oxidative stress in the protective effect of boric acid against glutamate excitotoxicity in C6 glioma cells
This study designed to investigate the biochemical changes in glial cells' oxidant/antioxidant systems in response to glutamate-induced excitotoxicity of boric acid (BA). The present study employed C6 glial cells. For the study, cells were separated into 4 groups as control, glutamate (10mM), glutamate+BA (0,23; 0,46; 0,93; 1,87 and 3,75 μg/mL), and BA (0,23; 0,46; 0,93; 1,87 and 3,75 μg/mL). The control group was not treated. The cells in the glutamate group were treated with 10 mM glutamate for 24 hours. BA was administered one hour prior to the addition of glutamate and incubated for 24 hours. The viability of the cells was evaluated using an XTT assay. Commercial kits were used for biochemical analyses. Significance was set at less than 0.05. The biochemical analysis revealed that the levels of malondialdehyde (MDA), nitric oxide (NO), inducible nitric oxide snythase (iNOS), neuronal nitric oxide synthase (nNOS), and total oxidant status (TOS) were elevated in the glutamate group compared to the control group (p
- 1 April 2025
- Published by Bor Dergisi in Journal of Boron
- Vol. 10 (1) , 1-9
Open AccessThe role of oxidative stress in the protective effect of boric acid against glutamate excitotoxicity in C6 glioma cells
This study designed to investigate the biochemical changes in glial cells' oxidant/antioxidant systems in response to glutamate-induced excitotoxicity of boric acid (BA). The present study employed C6 glial cells. For the study, cells were separated into 4 groups as control, glutamate (10mM), glutamate+BA (0,23; 0,46; 0,93; 1,87 and 3,75 μg/mL), and BA (0,23; 0,46; 0,93; 1,87 and 3,75 μg/mL). The control group was not treated. The cells in the glutamate group were treated with 10 mM glutamate for 24 hours. BA was administered one hour prior to the addition of glutamate and incubated for 24 hours. The viability of the cells was evaluated using an XTT assay. Commercial kits were used for biochemical analyses. Significance was set at less than 0.05. The biochemical analysis revealed that the levels of malondialdehyde (MDA), nitric oxide (NO), inducible nitric oxide snythase (iNOS), neuronal nitric oxide synthase (nNOS), and total oxidant status (TOS) were elevated in the glutamate group compared to the control group (p